4.9 C
London
HomeOtherTransfection Technologies Market Trends, Industry Size, Share, Growth and Report 2023-2028

Transfection Technologies Market Trends, Industry Size, Share, Growth and Report 2023-2028

The latest report by IMARC Group, titled “Transfection Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, offers a comprehensive analysis of the industry, which comprises insights on the global transfection technologies market trends. The global market size reached US$ 1,080.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,747.7 Million by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.

Transfection technologies refer to a set of techniques used in molecular biology and biotechnology to introduce foreign genetic material, such as DNA or RNA, into a host cell. This process plays a crucial role in various research endeavors, including gene expression studies, protein production, and the development of therapeutic interventions. Transfection methods can be broadly categorized into two main types: transient and stable transfection. In transient transfection, genetic material is introduced into cells for a short period, allowing the temporary expression of the introduced genes. This method is valuable for studying gene function and regulation in a controlled environment. On the other hand, stable transfection results in the long-term integration of foreign genes into the genome of the host cell. This is particularly useful for applications like the production of recombinant proteins or the creation of cell lines with specific genetic modifications.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/transfection-technologies-market/requestsample

Transfection Technologies Market Trends and Drivers:

The growing interest in gene therapy as a potential cure for genetic disorders and various diseases is propelling the transfection devices market. Clinical trials and successful gene therapy treatments are increasing the demand for transfection technologies that can efficiently deliver therapeutic genes. Additionally, the pharmaceutical industry heavily relies on transfection technologies to develop and test new drugs. Transfection devices are essential for drug discovery, target validation, and the development of biologics, including monoclonal antibodies and vaccines. Other than this, the presence of numerous academic and research institutions in the United States, engaged in cutting-edge genetic and molecular research, fuels the demand for transfection devices. These institutions require efficient tools to conduct experiments and advance scientific knowledge. Besides this, the rising incidence of genetic disorders and chronic diseases necessitates research into potential genetic treatments. Transfection technologies play a vital role in this research by enabling the delivery of therapeutic genes. In line with this, the continued growth of the biopharmaceutical industry, including the production of recombinant proteins and monoclonal antibodies, relies on transfection devices for cell line development and protein expression.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product Type:

  • Reagent
  • Instrument
  • Others

Breakup by Application:

  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production
  • Others

Breakup by Transfection Method:

  • Lipofection
  • Eletroporation
  • Nucleofection
  • Cotransfection
  • Cationic Lipid Transfection
  • In-Vivo Transfection
  • Others

Breakup by Technology:

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection

Breakup by End-User:

  • Research Centers and Academic Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Competitors Landscape with Key Players:

  • Agilent Technologies Inc.
  • Bio-RAD Laboratories Inc.
  • Lonza Group AG
  • Maxcyte Inc.
  • Mirus Bio LLC
  • Polyplus Transfection
  • Promega Corporation
  • Roche Holding AG
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

explore more